Geode Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.28M | Buy |
2,729,593
+42,916
| +2% | +$146K | ﹤0.01% | 2416 |
|
|
2025
Q1 | $10.8M | Buy |
2,686,677
+47,594
| +2% | +$191K | ﹤0.01% | 2246 |
|
|
2024
Q4 | $17.1M | Sell |
2,639,083
-28,921
| -1% | -$188K | ﹤0.01% | 2053 |
|
|
2024
Q3 | $14.8M | Buy |
2,668,004
+89,210
| +3% | +$494K | ﹤0.01% | 2146 |
|
|
2024
Q2 | $14.4M | Buy |
2,578,794
+70,778
| +3% | +$395K | ﹤0.01% | 2116 |
|
|
2024
Q1 | $16.8M | Buy |
2,508,016
+51,481
| +2% | +$345K | ﹤0.01% | 2025 |
|
|
2023
Q4 | $22.4M | Buy |
2,456,535
+102,083
| +4% | +$931K | ﹤0.01% | 1839 |
|
|
2023
Q3 | $13M | Buy |
2,354,452
+292,150
| +14% | +$1.61M | ﹤0.01% | 2098 |
|
|
2023
Q2 | $17.6M | Buy |
2,062,302
+192,832
| +10% | +$1.65M | ﹤0.01% | 1939 |
|
|
2023
Q1 | $17.2M | Buy |
1,869,470
+83,335
| +5% | +$766K | ﹤0.01% | 1906 |
|
|
2022
Q4 | $18.2M | Buy |
1,786,135
+55,467
| +3% | +$566K | ﹤0.01% | 1828 |
|
|
2022
Q3 | $25.5M | Buy |
1,730,668
+585,198
| +51% | +$8.61M | ﹤0.01% | 1561 |
|
|
2022
Q2 | $12.3M | Buy |
1,145,470
+224,330
| +24% | +$2.41M | ﹤0.01% | 2110 |
|
|
2022
Q1 | $9.93M | Buy |
921,140
+566,000
| +159% | +$6.1M | ﹤0.01% | 2346 |
|
|
2021
Q4 | $5.8M | Buy |
355,140
+34,032
| +11% | +$555K | ﹤0.01% | 2816 |
|
|
2021
Q3 | $6.87M | Buy |
+321,108
| New | +$6.87M | ﹤0.01% | 2722 |
|